Legis Daily

Drug-Free Communities Pandemic Relief Act

USA117th CongressHR-654| House 
| Updated: 10/21/2021
David P. Joyce

David P. Joyce

Republican Representative

Ohio

Cosponsors (3)
Warren Davidson (Republican)Derek Kilmer (Democratic)Tom Rice (Republican)

Judiciary Committee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Drug-Free Communities Pandemic Relief Act This bill authorizes the Drug-Free Communities Support Program, subject to certain limitations, to waive matching funds requirements applicable to certain grants for reducing substance use among youth. Before waiving these requirements, the program must determine that a grantee is unable to raise funds because of the COVID-19 emergency. Currently, the Office of National Drug Control Policy administers this program, and community coalitions that receive the grants must match a specified percentage of the federal award amount with nonfederal funds, including in-kind contributions.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7595
Drug-Free Communities Pandemic Relief Act
Jan 22, 2021

Latest Companion Bill Action

S 117-26
Introduced in Senate
Feb 1, 2021
Introduced in House
Feb 1, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Oct 19, 2021
Placed on the Union Calendar, Calendar No. 106.
Oct 19, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-146.
Oct 19, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 19, 2021
Considered under suspension of the rules. (consideration: CR H5650-5651)
Oct 19, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 654.
Oct 19, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 20, 2021
Considered as unfinished business. (consideration: CR H5700)
Oct 20, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 395 - 30 (Roll no. 321). (text: CR 10/19/2021 H5650)
View Vote
Oct 20, 2021
Motion to reconsider laid on the table Agreed to without objection.
Oct 20, 2021
The title of the measure was amended. Agreed to without objection.
Oct 21, 2021
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  • Bill from Previous Congress

    HR 116-7595
    Drug-Free Communities Pandemic Relief Act


  • January 22, 2021

    Latest Companion Bill Action

    S 117-26
    Introduced in Senate


  • February 1, 2021
    Introduced in House


  • February 1, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 2, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • October 19, 2021
    Placed on the Union Calendar, Calendar No. 106.


  • October 19, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-146.


  • October 19, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • October 19, 2021
    Considered under suspension of the rules. (consideration: CR H5650-5651)


  • October 19, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 654.


  • October 19, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • October 20, 2021
    Considered as unfinished business. (consideration: CR H5700)


  • October 20, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 395 - 30 (Roll no. 321). (text: CR 10/19/2021 H5650)
    View Vote


  • October 20, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • October 20, 2021
    The title of the measure was amended. Agreed to without objection.


  • October 21, 2021
    Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Health

Related Bills

  • S 117-26: Drug-Free Communities Pandemic Relief Act
Cardiovascular and respiratory healthDrug, alcohol, tobacco useEmergency medical services and trauma careHealth programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseases

Drug-Free Communities Pandemic Relief Act

USA117th CongressHR-654| House 
| Updated: 10/21/2021
Drug-Free Communities Pandemic Relief Act This bill authorizes the Drug-Free Communities Support Program, subject to certain limitations, to waive matching funds requirements applicable to certain grants for reducing substance use among youth. Before waiving these requirements, the program must determine that a grantee is unable to raise funds because of the COVID-19 emergency. Currently, the Office of National Drug Control Policy administers this program, and community coalitions that receive the grants must match a specified percentage of the federal award amount with nonfederal funds, including in-kind contributions.

Bill Text Versions

View Text
4 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-7595
Drug-Free Communities Pandemic Relief Act
Jan 22, 2021

Latest Companion Bill Action

S 117-26
Introduced in Senate
Feb 1, 2021
Introduced in House
Feb 1, 2021
Referred to the House Committee on Energy and Commerce.
Feb 2, 2021
Referred to the Subcommittee on Health.
Jul 15, 2021
Subcommittee Consideration and Mark-up Session Held.
Jul 15, 2021
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Jul 21, 2021
Committee Consideration and Mark-up Session Held.
Jul 21, 2021
Ordered to be Reported (Amended) by Voice Vote.
Oct 19, 2021
Placed on the Union Calendar, Calendar No. 106.
Oct 19, 2021
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-146.
Oct 19, 2021
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Oct 19, 2021
Considered under suspension of the rules. (consideration: CR H5650-5651)
Oct 19, 2021
DEBATE - The House proceeded with forty minutes of debate on H.R. 654.
Oct 19, 2021
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Oct 20, 2021
Considered as unfinished business. (consideration: CR H5700)
Oct 20, 2021
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 395 - 30 (Roll no. 321). (text: CR 10/19/2021 H5650)
View Vote
Oct 20, 2021
Motion to reconsider laid on the table Agreed to without objection.
Oct 20, 2021
The title of the measure was amended. Agreed to without objection.
Oct 21, 2021
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
  • Bill from Previous Congress

    HR 116-7595
    Drug-Free Communities Pandemic Relief Act


  • January 22, 2021

    Latest Companion Bill Action

    S 117-26
    Introduced in Senate


  • February 1, 2021
    Introduced in House


  • February 1, 2021
    Referred to the House Committee on Energy and Commerce.


  • February 2, 2021
    Referred to the Subcommittee on Health.


  • July 15, 2021
    Subcommittee Consideration and Mark-up Session Held.


  • July 15, 2021
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • July 21, 2021
    Committee Consideration and Mark-up Session Held.


  • July 21, 2021
    Ordered to be Reported (Amended) by Voice Vote.


  • October 19, 2021
    Placed on the Union Calendar, Calendar No. 106.


  • October 19, 2021
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-146.


  • October 19, 2021
    Mr. Pallone moved to suspend the rules and pass the bill, as amended.


  • October 19, 2021
    Considered under suspension of the rules. (consideration: CR H5650-5651)


  • October 19, 2021
    DEBATE - The House proceeded with forty minutes of debate on H.R. 654.


  • October 19, 2021
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • October 20, 2021
    Considered as unfinished business. (consideration: CR H5700)


  • October 20, 2021
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 395 - 30 (Roll no. 321). (text: CR 10/19/2021 H5650)
    View Vote


  • October 20, 2021
    Motion to reconsider laid on the table Agreed to without objection.


  • October 20, 2021
    The title of the measure was amended. Agreed to without objection.


  • October 21, 2021
    Received in the Senate and Read twice and referred to the Committee on the Judiciary.
David P. Joyce

David P. Joyce

Republican Representative

Ohio

Cosponsors (3)
Warren Davidson (Republican)Derek Kilmer (Democratic)Tom Rice (Republican)

Judiciary Committee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 117-26: Drug-Free Communities Pandemic Relief Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthDrug, alcohol, tobacco useEmergency medical services and trauma careHealth programs administration and fundingHealth promotion and preventive careInfectious and parasitic diseases